Skip Navigation



Carcinogenesis Advance Access published online on July 13, 2005
Carcinogenesis, doi:10.1093/carcin/bgi181
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
26/12/2213    most recent
bgi181v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Benusiglio, P. R.
Right arrow Articles by Pharoah, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benusiglio, P. R.
Right arrow Articles by Pharoah, P. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oupjournals.org
Received June 22, 2005
Accepted July 4, 2005

LETTER TO THE EDITOR

Re: a bias in genotyping of the ERBB2 (HER2) Ile655Val variant

Patrick R. Benusiglio 1*, Craig Luccarini 1, Oluseun Ajai 1, Bruce A. J. Ponder 1, and Paul D. Pharoah 1

1 Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Wort's Causeway, Cambridge CB1 8RN, United Kingdom

* To whom correspondence should be addressed.
Patrick R. Benusiglio, E-mail: pbenusiglio{at}yahoo.com



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.